Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
None USD 0.00(0%)
Last update at 2025-05-02T13:01:19.179680Z
Market Cap
778.42M

Momentum Score

…

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
13.98
Low
41.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
422.84M
Revenue Per Share
11.82
Gross Profit TTM
276.37M
Debt / Equity
0.61
ROE
-33.55%
Net Debt
76.79M
ROCE
-18.89%
Diluted EPS TTM
-2.87

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 4.26M -130.83M -82.20M -102.09M -48.44M
Net income 3.00M -131.36M -83.06M -103.69M -49.20M
Selling general administrative 322.14M 309.31M 267.15M 305.81M 266.61M
Gross profit 276.37M 266.04M 249.90M 268.35M 273.32M
Reconciled depreciation 10.33M 8.68M 8.19M 7.80M 3.89M
Ebit -98.84M -90.93M -71.04M -104.28M -45.63M
Ebitda -203.84M -70.93M -62.85M -96.48M -41.74M
Depreciation and amortization -105.00M 20.00M 8.19M 7.80M 3.89M
Non operating income net other 4.53M -0.14M 2.46M 5.32M 3.71M
Operating income -98.84M -90.93M -62.85M -96.48M -41.74M
Other operating expenses 505.20M 477.84M 424.90M 486.73M 429.03M
Interest expense 6.43M 19.75M 21.81M 10.93M 10.40M
Tax provision 1.26M 0.53M 0.87M 1.60M 0.77M
Interest income 4.02M 0.67M 2.96M 6.02M 4.87M
Net interest income -2.41M -19.08M -18.85M -4.91M -5.53M
Non recurring -105.00M 20.00M - - -
Income tax expense 1.26M 0.53M 0.87M 1.60M 0.77M
Total revenue 406.37M 386.90M 362.05M 390.25M 387.29M
Total operating expenses 375.20M 356.98M 312.75M 364.83M 315.07M
Cost of revenue 130.00M 120.86M 112.15M 121.91M 113.97M
Total other income expense net 103.10M -39.89M -19.34M -5.61M -1.16M
Net income from continuing ops 3.00M -131.36M -83.06M -103.69M -49.20M
Net income applicable to common shares 3.00M -131.36M -83.06M -103.69M -49.20M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 602.41M 574.54M 789.43M 469.64M 463.12M
Other current assets 9.98M 5.18M 4.17M 9.84M 6.62M
Total liab 278.53M 270.93M 400.97M 253.29M 217.63M
Total stockholder equity 323.88M 303.62M 388.46M 216.35M 245.48M
Other current liab 52.36M 50.20M 3.98M 54.56M 38.91M
Common stock 0.04M 0.04M 0.04M 0.03M 0.03M
Capital stock 0.04M 0.04M 0.04M 0.03M 0.03M
Retained earnings -607.20M -624.19M -492.83M -409.77M -306.08M
Other liab 2.16M 22.01M 3.34M 1.94M 2.83M
Other assets 3.77M 5.10M 22.79M 14.29M 6.46M
Cash 120.37M 34.71M 44.60M 65.37M 51.27M
Total current liabilities 79.21M 82.20M 239.16M 70.61M 62.41M
Current deferred revenue - - 43.30M - -
Net debt 76.79M 132.00M 282.64M 115.37M 101.13M
Short term debt - - 168.78M - -
Short long term debt - - 168.78M - -
Short long term debt total 197.16M 166.71M 327.24M 180.75M 152.39M
Other stockholder equity 934.13M 928.14M 880.66M 626.40M 552.53M
Property plant equipment 22.27M 20.66M 13.53M 11.77M 12.80M
Total current assets 562.94M 531.20M 753.11M 422.05M 443.86M
Net tangible assets 323.88M 303.62M 388.46M 216.35M 245.48M
Short term investments 254.01M 327.32M 543.37M 172.43M 213.28M
Net receivables 78.93M 70.47M 77.67M 82.83M 80.66M
Long term debt 186.87M 151.31M 141.77M 160.30M 152.39M
Inventory 99.64M 93.52M 83.30M 91.58M 92.03M
Accounts payable 26.85M 32.00M 23.11M 16.05M 23.50M
Accumulated other comprehensive income -3.09M -0.36M 0.60M -0.31M -1.08M
Common stock total equity 0.04M 0.04M 0.04M 0.03M 0.03M
Retained earnings total equity -607.20M -624.19M -492.83M -409.77M -306.08M
Non currrent assets other 3.77M 5.10M 4.65M 14.29M 6.46M
Non current assets total 39.47M 43.34M 36.32M 47.59M 19.26M
Capital lease obligations 10.30M 15.40M 16.69M 20.45M -
Long term debt total 186.87M 151.31M 141.77M 160.30M 152.39M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 71.83M 214.06M -371.34M 43.30M 14.65M
Change to liabilities -27.95M 26.35M -2.57M 2.91M 5.89M
Total cashflows from investing activities 64.29M 201.72M -369.87M 32.33M 6.43M
Net borrowings - -172.50M 137.36M 189.75M 189.75M
Total cash from financing activities -2.46M -169.38M 346.90M 32.09M 7.75M
Change to operating activities -25.80M 15.86M -2.78M 7.67M -2.65M
Net income 3.00M -131.36M -83.06M -103.69M -49.20M
Change in cash 85.66M -9.89M -21.13M 14.46M 8.22M
Begin period cash flow 35.32M 45.20M 66.33M 51.87M 43.65M
End period cash flow 120.98M 35.32M 45.20M 66.33M 51.87M
Total cash from operating activities 24.68M -41.88M 1.19M -50.23M -5.71M
Issuance of capital stock 0.00M 0.00M 147.14M 35.15M 9.50M
Depreciation 10.33M 8.68M 8.19M 7.80M 3.89M
Other cashflows from investing activities - - 7.50M -7.50M -7.50M
Change to inventory -7.83M -17.23M 2.52M -0.94M 3.85M
Change to account receivables -9.61M 8.21M 3.37M -2.15M -12.21M
Sale purchase of stock 6.39M 11.18M 224.21M 35.15M 9.50M
Other cashflows from financing activities -2.46M -8.06M 199.76M -3.06M -1.74M
Change to netincome 61.27M 47.10M 50.20M 43.13M 38.14M
Capital expenditures 7.54M 12.34M 6.03M 3.47M 8.22M
Change receivables -9.61M 8.21M 3.37M -2.15M -12.21M
Cash flows other operating -2.01M 5.40M 10.68M 0.08M -2.18M
Cash and cash equivalents changes 86.51M -9.55M -21.77M 14.20M 8.48M
Change in working capital -48.89M 15.85M 10.79M -2.89M -5.84M
Stock based compensation 56.80M 44.37M 42.66M 41.70M 36.64M
Other non cash items 3.44M 13.26M 14.95M 7.91M 7.38M
Free cash flow 17.13M -54.22M -4.83M -53.70M -13.93M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ABT
Abbott Laboratories
-
-%
104.48 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-1.43
1.40%
100.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
0.19
0.06%
318.15 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-0.10
0.22%
47.50 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Nevro Corp

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

1800 Bridge Parkway, Redwood City, CA, United States, 94065

650 251 0005

1087

Name Title Year Born
Mr. D. Keith Grossman Chairman, CEO & Pres 1960
Mr. Roderick H. MacLeod Chief Financial Officer 1967
Mr. Kashif Rashid Gen. Counsel, Corp. Sec. & Chief Compliance Officer 1974
Ms. Niamh Louise Pellegrini Chief Commercial Officer 1967
Mr. Patrick Schmitz VP of Operations 1960
Mr. Richard B. Carter Chief Accounting Officer 1971
Ms. Julie D. Dewey Chief Corp. Communications & Investor Relations Officer 1961
Mr. Michael Collier Carter VP of Global Sales 1972
Mr. Jon R. Shear VP of Corp. Devel. NA
Meredith Vornholt VP of Global Marketing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…